Status:
COMPLETED
Evaluation of Therapeutic Adherence to Inciting Spirometry in Sickle Cell Patients
Lead Sponsor:
Centre Hospitalier Intercommunal Creteil
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
18+ years
Brief Summary
Sickle cell disease is one of the most common genetic diseases in the world. (1) It is characterized by the production of abnormal hemoglobin mainly responsible for vaso-occlusive clinical manifestati...
Eligibility Criteria
Inclusion
- Patients with sickle cell disease,
- Major
- No opposition for participation in the protocol
Exclusion
- Patients unable to answer the questionnaire due to linguistic or other problems
- Patients under guardianship or curatorship
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04667325
Start Date
January 1 2021
End Date
February 1 2021
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier intercommunal de Créteil
Créteil, France, 94000